Arctiin targets oxidative stress and inflammation, restores Neuregulin-1, and improves neurobehavioral outcomes in neonatal hypoxic-ischemic brain injury. // Current Research in Pharmacology and Drug Discovery. – URL: https://www.sciencedirect.com/science/article/pii/S2590257126000040?dgcid=rss_sd_all
Arctiin targets oxidative stress and inflammation, restores Neuregulin-1, and improves neurobehavioral outcomes in neonatal hypoxic-ischemic brain injury. Current Research in Pharmacology and Drug Discovery. https://www.sciencedirect.com/science/article/pii/S2590257126000040?dgcid=rss_sd_all
“Arctiin targets oxidative stress and inflammation, restores Neuregulin-1, and improves neurobehavioral outcomes in neonatal hypoxic-ischemic brain injury.” Current Research in Pharmacology and Drug Discovery.
@article{article2928,
title = {Arctiin targets oxidative stress and inflammation, restores Neuregulin-1, and improves neurobehavioral outcomes in neonatal hypoxic-ischemic brain injury},
journal = {Current Research in Pharmacology and Drug Discovery},
url = {https://www.sciencedirect.com/science/article/pii/S2590257126000040?dgcid=rss_sd_all}
}